Erschienen in:
21.06.2017 | Letter to Editor
IFNɣ Block, Treosulfan Conditioning and αβ T Cell Deplete PBSCT for XIAP-Deficient HLH
verfasst von:
Ciara O’Rafferty, Mark Velangi, Sarah Lawson, Prashant Hiwarkar, Jayashree Motwani
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 6/2017
Einloggen, um Zugang zu erhalten
Excerpt
The outcomes of hematopoietic stem cell transplantation (HSCT) for refractory hemophagocytic lymphohistiocytosis (HLH) in X-linked inhibitor of apoptosis protein (XIAP) deficiency are poor [
1]. Amongst other functions, XIAP regulates apoptosis in hepatocytes and other cells and its deficiency may result in increased sensitivity to chemotherapy. A high rate of transplant-related mortality (TRM) is observed following both myeloablative and reduced-intensity conditioning regimens. Treatment-related mortality is attributed to uncontrolled HLH and increased sensitivity to chemotherapeutic agents. Hence, there is a need for both novel agents to control HLH and reduced-toxicity transplantation techniques. …